Multiplexed Immunoassay Service helps researchers to monitor the levels of multiple cytokines in a single sample simultaneously. It can be implemented in various applications that covering pathogen detection, drug discovery, biomarker discovery, vaccine development, and cancer research. In particular, Multiplexed Immunoassay Service is useful for CAR-T development to monitor cytokine profiles of in vitro and in vivo experiment studies. Equipped with state-of-the-art facilities and the largest immediately available retail analyte selection system, Creative Biolabs is dedicated to providing customized Multiplexed Immunoassays services for our global customers.
The Multiplexed Immunoassay technology is a beads-based immunoassay that offers high-throughput detection of both protein and nucleic acid targets in multiple assay chemistries. Multiplexed Immunoassay, which allows for multiplex detection of up to 100 analytes simultaneously in one sample, can greatly reduce time, labor, and cost as compared to single-reaction-based detection methods.
The Multiplexed Immunoassay has been implemented in a variety of applications that range from transplant medicine, biomarker discovery and validation, pathogen detection, drug discovery, vaccine development, personalized medicine, neurodegeneration, and cancer research.
Fig.1 How the Multiplexed Immunoassay works.1
Based on a suspension array, the platform contains capture moieties that are covalently coupled with dyed microspheres internally, also includes phycoerythrin-labeled antibodies binding to the specific antigen-antibody complex on the bead sets. Then, a Multiplexed Immunoassay instrument recognizes the response and analyses the difference in both bead sets, to identify the bead area and corresponding assigned analyte. The Multiplexed Immunoassay system allows covalent coupling and detection of respective different types of molecules or macroparticles.
Creative Biolabs provides customized Multiplexed Immunoassay service for multiple targets analysis, which allows you to carefully choose compatible targets and build your assay using analytes of optimized choice.
Creative Biolabs focuses on the following targets panels, but not limited to:
| Human Cytokine/Chemokine | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Human Adipokine | Human Angiogenesis | Human Soluble Cytokine Receptor |
| Adiponectin | Angiopoietin-2 | CD25/IL-2 R alpha |
| HGF | BMP-9 | CD30 |
| IL-1 beta | EGF | gp130 |
| IL-6 | Endoglin | IL-1 RI |
| IL-8/CXCL8 | Endothelin-1 | IL-1 RII |
| Leptin | FGF acidic | IL-4 R alpha |
| MCP-1/CCL2 | FGF basic | IL-6 R alpha |
| beta-NGF | G-CSF | RAGE |
| Serpin E1/PAI-1 | HB-EGF | TNF RI |
| …… | …… | …… |
Available samples for detection including human, mouse, and rat samples, which can be serum, plasma, and cell culture media types.
As an experienced customization service provider, Creative Biolabs can provide highly efficient and convenient strategies to satisfy your research demands, please feel free to contact us.
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION